The U.S. coronavirus death toll has surpassed 130,000 but a U.S. pharmaceutical company says it could have initial doses of a drug ready by the end of summer that could treat or even prevent COVID-19. A $450 million federal contract awarded Regeneron Pharmaceuticals could help get the drug to “many […]